Potentiated vaccine for
global immunization
Innovative technology for novel vaccine
Cold chain free nasal vaccine
Peptide vaccine without pathogen
Cancer therapeutic vaccine for melanoma and HPV
A nasal stroke therapeutic drug
![]() | Dongho Kim, Ph.D. CEO Ph.D. University of Texas at AustinPostdoc. in Beckman Research Institute of City of Hope Staff Scientist/Director of RNAi core of Beckman Research Institute of COH CEO and Founder of Cellonex, Genolution, IRI Pharma, NA Vaccine Institute Adjunct Professor, POSTECH |
---|---|
![]() | Myung-soo Kang, Ph.D. COO Seoul National UniversityInstructor at Harvard Medical School Professor at Samsung Medical Center Director at Intron Biotechnology |
![]() | John Rossi, Ph.D. Board director of scientific advisoryChair and Professor, Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope. A World Leader in RNAi and in clinical research with nucleic acids. Co-founder of Dicerna Pharmaceuticals, Calando Pharmaceuticals, Inc. |
![]() | Hwanmook Kim, Ph.D. KAIST Professor, Gachn University |
![]() | Won Jong Kim, Ph.D. Scientific Advisor Ph.D.Tokyo Institute of Technology Postdoc. in University of Utah Mueunjae Chaired Professor, POSTECH |
![]() | Taerim Yun, CFO Sungkyunkwan University, MBASK Telecom Team Leader , SK Planet Project Leader Specialist in Finance, M&A, Venture Fund Investment, Business Portfolio Management |